Parecer de pré-exame
#6.23
08/06/2024
RPI 2796
Application data
Number
112019021482Type
Filing
Publication
PCT
US2018027271 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 08/06/2024. We update with every new RPI gazette, published weekly.
Applicants
AMGEN INC.
US
MEDIMMUNE LLC
US
Inventors
J. P. (pessoa física)
US
J. G. (pessoa física)
US
IPC Classification
Priority claims
US
62/484,864 · 04/12/2017
US
62/553,477 · 09/01/2017
US
62/553,575 · 09/01/2017
Abstract
A presente divulgação se refere, em geral, a métodos de tratamento da asma, incluindo asma grave e asma eosinofílica, utilizando um anticorpo específico para linfopoietina do estroma tímica (TSLP).
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
08/06/2024
RPI 2796
#15.35
10/19/2021
RPI 2650
#1.3
05/12/2020
RPI 2575
#1.1
10/22/2019
RPI 2546
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.